loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations
Open ICICI 3-in-1 Account

Sharda Cropchem Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Sharda Cropchem Ltd. 13 May 2026 15:50 PM
Result PDF

Q4FY26 & FY26 Result Announced for Sharda Cropchem Ltd.

Agrochemicals company Sharda Cropchem announced Q4FY26 & FY26 results

Consolidated Financial Highlights:

  • Total Income for Q4FY26 stood at Rs 2,08,734.58 lakh, representing an increase of 59.34% QoQ from Rs 1,30,999.98 lakh in Q3FY26 and a growth of 12.60% YoY from Rs 1,85,375.98 lakh in Q4FY25.
  • Revenue from Operations in Q4FY26 was Rs 2,06,490.05 lakh compared to Rs 1,82,852.52 lakh in Q4FY25, marking a 12.93% YoY growth.
  • Profit before Tax for Q4FY26 reached Rs 42,208.11 lakh, which is a 136.38% QoQ increase from Rs 17,856.22 lakh in Q3FY26 and a 64.81% YoY increase from Rs 25,610.65 lakh in Q4FY25.
  • Net Profit after Tax (PAT) for Q4FY26 was Rs 31,872.37 lakh, reflecting a significant growth of 119.64% QoQ from Rs 14,511.45 lakh in Q3FY26 and an increase of 56.54% YoY from Rs 20,360.26 lakh in Q4FY25.
  • Annual Total Income for FY26 stood at Rs 5,37,313.26 lakh, representing a 22.69% YoY increase compared to Rs 4,37,938.75 lakh in FY25.
  • Annual Net Profit (PAT) for FY26 reached Rs 68,099.15 lakh, marking an increase of 123.70% YoY from Rs 30,441.76 lakh in FY25.
  • Basic Earnings per share for FY26 stood at Rs 75.47 compared to Rs 33.74 in FY25.

Standalone Financial Highlights:

  • Total Income for Q4FY26 was Rs 1,96,284.11 lakh, an increase of 64.72% QoQ from Rs 1,19,163.58 lakh in Q3FY26 and a growth of 16.86% YoY from Rs 1,67,968.40 lakh in Q4FY25.
  • Net Profit after Tax (PAT) for Q4FY26 was Rs 35,240.39 lakh, showing a 110.75% QoQ growth from Rs 16,721.25 lakh in Q3FY26 and a 92.50% YoY increase from Rs 18,306.41 lakh in Q4FY25.
  • Annual Total Income for FY26 reached Rs 4,87,119.01 lakh, up 26.97% YoY from Rs 3,83,586.39 lakh in FY25.
  • Annual Net Profit (PAT) for FY26 stood at Rs 67,731.89 lakh, a growth of 147.43% YoY compared to Rs 27,373.64 lakh in FY25.
  • Dividend: The Board of Directors recommended a final dividend of Rs 9.00 per equity share of face value of Rs 10.00 each for FY26. Including the interim dividend of Rs 6.00 paid in December 2025, the total dividend for FY26 is Rs 15.00 per share.

Business Highlights:

  • Segment Performance (Agrochemicals): In FY26, the Agrochemicals segment reported revenue of Rs 4,71,685.90 lakh, marking a 25.02% YoY growth from Rs 3,77,296.93 lakh in FY25. Segment results (profit) for Agrochemicals reached Rs 68,487.56 lakh in FY26 compared to Rs 23,002.75 lakh in the previous year.
  • Segment Performance (Non-agrochemicals): This segment contributed Rs 55,072.62 lakh to revenue in FY26, a marginal increase of 0.70% YoY. Segment profit stood at Rs 14,378.13 lakh for the year.
  • Region-wise Agrochemical Performance (FY26):
    • Europe: Revenue reached Rs 2,981 crore, a growth of 37% YoY.
    • NAFTA: Revenue reached Rs 1,266 crore, a growth of 3% YoY.
    • LATAM: Revenue reached Rs 254 crore, a growth of 33% YoY.
    • Rest of World (RoW): Revenue reached Rs 216 crore, a growth of 21% YoY.
  • Product-wise Agrochemical Performance (FY26):
    • Herbicides: Revenue of Rs 2,410 crore, up 21% YoY.
    • Insecticides: Revenue of Rs 1,005 crore, up 39% YoY.
    • Fungicides: Revenue of Rs 1,302 crore, up 24% YoY.
  • Profitability Ratios: The company achieved its highest-ever Return on Capital Employed (RoCE) of 30.4% for FY26.
  • Financial Position: The company remains debt-free with cash, bank, and liquid investments totaling Rs 702 crore as of March 31, 2026.
  • Product Registrations: As of March 31, 2026, the group has 3,011 product registrations with 1,004 applications pending at various stages.

 Ramprakash Bubna, Chairman and MD, said: “FY26 has been a landmark year for Sharda Cropchem. Our revenue grew 22% to Rs. 5,268 crore, driven by strong volume momentum, an improved product mix, and the accelerating contribution of our expanding registration pipeline across geographies. This strategic investment in registrations is now visibly translating into sustainable top-line growth.

EBITDA grew 69% to Rs. 1,040 crore, with margins expanding meaningfully to 19.7%. Our PAT more than doubled to Rs. 681 crore — a 124% growth year-on-year — reflecting the operating leverage in our model as scale and efficiency come together.

We are also proud to report our highest-ever Return on Capital Employed of 30.4% for FY26, a testament to disciplined capital allocation and the inherent strength of our asset-light business model. As we look ahead, the Company is well-positioned to sustain this momentum, and we enter FY27 with confidence backed by a robust registration base, expanding market presence, and a resilient operating framework.”

Result PDF

Result PDF

Agrochemicals company Sharda Cropchem announced Q3FY26 results

  • Revenue: Rs 1,288.8 crore against Rs 929.3 crore during Q3FY25, change 39%.
  • EBITDA: Rs 245.5 crore against Rs 154.2 crore during Q3FY25, change 59%.
  • EBITDA Margin: 19.1% for Q3FY26.
  • PBT: Rs 450.3 crore against Rs 304.2 crore during Q3FY25, change 48%.
  • PAT: Rs 145.1 crore against Rs 31.1 crore during Q3FY25, change 367%.
  • EPS: 16.09 for Q3FY26.

Ramprakash Bubna, Chairman & MD, said: “In Q3FY26, we delivered robust revenue growth of 39% YoY to Rs 1,289 crore, mainly driven by a mix of volume and product mix. Europe has led as the key contributor in both volume and value terms.

With input costs stabilizing, improving price dynamics and change in product mix, the Company’s Gross Margins has expanded by 220 basis points to 34.9% and we expect GP Margins to remain in a similar range going ahead. We expect prices to go up going forward. EBITDA has grown by 59% to Rs 246 crore with EBITDA Margins at 19.1%, an increase of 250 basis points on YoY basis.

For 9MFY26, revenues grew 29% to Rs 3,203 crore with EBITDA increasing 64% to Rs 527 crore. The Company has already achieved its highest-ever annual PAT within the first nine months of FY26 of Rs 362 crore.

The Company expects the growth momentum to continue in Q4FY26 and remain strong in FY27.”

Result PDF

Agrochemicals company Sharda Cropchem announced Q2FY26 results

  • Revenue: Rs 929.1 crore compared to Rs 776.9 crore during Q2FY25, change 20%.
  • EBITDA: Rs 138.9 crore compared to Rs 81.3 crore during Q2FY25, change 71%.
  • EBITDA Margin: 15.0% for Q2FY26.
  • PAT: Rs 74.4 crore compared to Rs 42.4 crore during Q2FY25, change 75%.

Ramprakash Bubna, Chairman & MD, said: “In Q2FY26, we delivered robust revenue growth of 20% YoY to Rs 929 crore, mainly driven by volumes. NAFTA and Europe remains a key contributors in both volume and value terms.

With input costs stabilizing and improving price dynamics, Gross Margins has expanded by 690 basis points to 34.5% and we expect GP Margins to remain in a similar range going ahead. We expect prices to go up going forward. EBITDA has grown by 71% to Rs ~139 crore with EBITDA Margins at 15.0% (improved by 450 bps on Y-o-Y basis). For FY26, we are on track to maintain healthy EBITDA margins in the range of 15–18%.

We remain committed to accelerating product registrations in FY26, supported by a planned capital expenditure of Rs 450–500 crore. Our strong registration pipeline of 1,068 underscores our resilience and sustained growth focus, positioning us well for the long term.”

Result PDF

Agrochemicals company Sharda Cropchem announced Q1FY26 results

  • Revenue: Rs 984.8 crore compared to Rs 785.1 crore during Q1FY25, change 25%.
  • Gross Profit: Rs 349.2 crore compared to Rs 228.9  crore during Q1FY25, change 53%.
  • Gross Profit Margin: 35.5% for Q1FY26.
  • EBITDA: Rs 142.2  crore compared to Rs 85.4 crore during Q1FY25, change 67%.
  • EBITDA Margin: 14.4% for Q1FY26.
  • PAT: Rs 142.8  crore compared to Rs 27.3 crore during Q1FY25, change 424%.

Ramprakash Bubna, Chairman & MD, said: “In Q1FY26, we recorded strong volume growth of ~13%, with revenues rising ~25% YoY to Rs 985 crore. This performance was driven by a global demand revival and improved pricing. Europe remains a key contributor in both volume and value terms.

With input costs stabilizing, our Gross Margins has expanded by 630 basis points to 35.5% and we expect GP Margins to remain in a similar range going ahead. EBITDA has grown by 67% to Rs 142 crore with EBITDA Margins at 14.4%.

We remain focused on increasing our product registrations in FY26, with planned capex of ~Rs 400-450 crore. Our strong pipeline of registrations reflects both our resilience and unwavering commitment to growth, laying a strong foundation for sustained future progress.

For FY26, we aim to grow our topline by ~15% while maintaining healthy EBITDA Margins in the range of 15–18%.”

Result PDF

Agrochemicals company Sharda croreopchem announced Q4FY25 & FY25 results

Q4FY25 Financial Highlights:

  • Revenue from Operations: Rs 1,828.5 crore in Q4FY25 vs. Rs 1,312.1 crore in Q4FY24 — up 39%
  • Gross Profit: Rs 544.0 crore in Q4FY25 vs. Rs 453.8 crore in Q4FY24 — up 20%
  • Gross Profit Margin: 29.8% in Q4FY25 vs. 34.6% in Q4FY24 — down 480 bps
  • EBITDA: Rs 351.8 crore in Q4FY25 vs. Rs 302.7 crore in Q4FY24 — up 16%
  • EBITDA Margin: 19.2% in Q4FY25 vs. 23.1% in Q4FY24 — down 390 bps
  • PAT: Rs 203.6 crore in Q4FY25 vs. Rs 143.5 crore in Q4FY24 — up 42%

FY25 Financial Highlights:

  • Revenue from Operations: Rs 4,319.9 crore in FY25 vs. Rs 3,163 crore in FY24 — up 37%
  • Gross Profit: Rs 1,291.8 crore in FY25 vs. Rs 820.6 crore in FY24 — up 57%
  • Gross Profit Margin: 29.9% in FY25 vs. 25.9% in FY24 — up 400 bps
  • EBITDA: Rs 681.6 crore in FY25 vs. Rs 318.1 crore in FY24 — up 114%
  • EBITDA Margin: 15.8% in FY25 vs. 10.1% in FY24 — up 570 bps
  • PAT: Rs 304.4 crore in FY25 vs. Rs 31.9 crore in FY24 — up 854%

Commenting on the Results, Ramprakash Bubna, Chairman and MD, said, “During Q4 FY25, the Company has witnessed a revival in demand with Revenues growing by 39% YoY to Rs 1,829 crore despite facing ongoing global challenges and sustained pricing pressures. This resurgence has translated into a strong operational and financial performance in Q4 FY25, reflecting resilience in our business model and the effectiveness of the initiatives taken.

For FY25, Revenues grew by 37% YoY to Rs 4,320 crore. Gross profit margins expanded by 400 basis points to 29.8%, demonstrating our pricing resilience amid global headwinds. EBITDA more than doubled to Rs 682 crore, with EBITDA margins at 15.8%, aligning with our guidance. Agrochemical volumes saw a robust growth of 44% during the year.

With raw material prices stabilising, we expect consistency in gross margins going ahead. Our strong pipeline of registrations reflects both our resilience and unwavering commitment to growth, laying a strong foundation for sustained future progress. We are confident on our ongoing plan to increase product registrations in FY26 with capex guidance of Rs 400-450 crore.

For FY26, we aim to grow our topline by more than 15% while maintaining healthy EBITDA margins in the range of 15–18%.”

Result PDF

Agrochemicals company Sharda Cropchem announced Q3FY25 results

  • Revenue: Rs 929.3 crore compared to Rs 632.5 crore during Q3FY24, change 47%.
  • Gross Profit: Rs 304.2 crore compared to Rs 165.6 crore during Q3FY24, change 84%.
  • Gross Profit Margin: 32.7% for Q3FY25.
  • EBITDA: Rs 156.6 crore compared to Rs 47.2 crore.
  • EBITDA Margin: 16.9% for Q3FY25.
  • PAT: Rs 31.1 crore compared to Rs 4.6 crore during Q3FY24.

Ramprakash Bubna, Chairman and MD, said: “Despite the ongoing global headwinds and persistent pricing pressures, we have seen a revival in demand which has led to a strong performance in Q3FY25

Revenue in Q3FY25 increased by 47%, primarily driven by higher volumes. We saw volume growth across all regions, with Europe, NAFTA and LATAM being key drivers. Agrochemical volumes grew by 49.5% in Q3FY25. With raw material prices stabilising, we have managed to expand the gross margin by 660 bps to 32.7%. We have been working on cost optimization strategies and with operating leverage playing out, we have been able to improve our EBITDA Margins to 16.9% for the quarter.

Our strong pipeline of registrations showcases our resilience and our commitment to growth which establishes a solid foundation for continued progress.

We are confident on our ongoing plan to increase product registrations in FY25 with capex guidance of Rs 400-450 crore enabling us to meet FY25 guidance.”

Result PDF

Agrochemicals company Sharda Cropchem announced Q2FY25 results

Financial Highlights:

  • Revenue: Rs 776.9 crore, compared to Rs 580.8 crore during the period Q2FY24, change 34%.
  • Gross profit: Rs 214.7 crore, compared to Rs 145.5 crore during the period Q2FY24, change 48%.
  • Gross profit Margin: 25.1%.
  • EBITDA: Rs 84.4 crore, compared to Rs 37.7 crore during the period Q2FY24, change 125%.
  • EBITDA margin: 6.5%.
  • PAT: Rs 42.4 crore, compared to Rs -27.6 crore during the period Q2FY24.

Business Highlights:

  • Agrochemical Segment contributes 82%; Non-Agrochemical Segment contributes 18%.
  • Overall Volumes have increased by 20.6% YoY in Q2FY25; Agrochemical volumes grew by 24.6%
  • Agrochemical Segment contributes 84%; Non-Agrochemical Segment contributes 16%.
  • Overall Volumes have increased by 30.3% YoY in H1FY25; Agrochemical volumes grew by 36.0%.
  • Capex in H1FY25 stands at ~Rs. 155 crore.
  • Product Registrations stand at 2,934 with 1,034 applications globally pending at various stages as on 30th September 2024.
  • We remain a debt free company with cash, bank & liquid investments of Rs. 656 crore.

Ramprakash Bubna, Chairman and MD, said: “Despite the global industry challenges, including subdued demand and pricing pressures, we have delivered strong performance in Q2 and H1FY25 compared to last year. Revenue in Q2FY25 increased by 34%, and H1FY25 by 28%, primarily driven by higher volumes and a gradual price increase. We saw volume growth across all regions, with Europe and NAFTA being key contributors. Agrochemical volumes grew by 24.6% in Q2FY25 and by 36.0% in H1FY25. We are optimistic about improving gross margins moving forward.

Our extensive pipeline of registrations showcases our resilience and our commitment to growth. To drive sustainable growth, we intensify our focus on operational efficiencies. This enhances profitability and organizational agility, ensuring a strong foundation for future growth.

We are happy to emphasize our ongoing plan to increase product registrations in FY25 with capex guidance of Rs. 400-450 crore is on track driving revenue growth, improved competitiveness, and increased customer satisfaction.”

Result PDF

Agrochemicals company Sharda Cropchem announced Q1FY25 results:

  • Revenue: Rs 785.1 crore (up 23% YoY)
  • Gross Profit: Rs 228.9 crore (up 311% YoY)
  • Gross Profit Margin (%): 29.2% (up from 8.7% in Q1FY24)
  • EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization): Rs 88.3 crore (from -Rs 66.0 crore in Q1FY24)
  • EBITDA Margin (%): 11.3% (improvement from -10.4% in Q1FY24)
  • PAT (Profit After Tax): Rs 27.3 crore (from -Rs 88.6 crore in Q1FY24)

Commenting on the Results, Ramprakash Bubna, Chairman and MD, said : “In Q1FY25, we recorded an improvement in financial results on YoY basis despite a challenging market environment. Revenue has grown by 23% majorly due to growth in volumes by 41% as compared to last year. We have seen volume growth across all major regions with Europe nearly doubling. Volumes from Agrochemicals grew by 49%. Gross Margins at 29.2% have come back to normalcy and we expect this to improve in this financial year with prices expected to increase. This enhances profitability and organisational agility, ensuring a strong foundation for future growth.

As we look ahead, we aim to increase our product registrations and expect Capex of ~Rs 400-450 crores on the same in FY25 and expand our global presence.” 

Result PDF

Agrochemicals company Sharda Cropchem Announced Q1FY23 Result :

  • Revenue growth led by better price realization and product mix.
  • Gross Margins have been impacted by weakening of €/$ and increase in freight costs
  • EBITDA and Margin impacted due to lower GP Margins and increase in freight costs .
  • PAT was impacted by higher depreciation and forex losses of Rs. Rs. 43.2 cr. in Q1 FY23 vs. Gain of Rs. 11.5 cr. in Q1 FY22 impacting to the tune of Rs. 54.7 Crs.

 

Result PDF

Agrochemicals company Sharda Cropchem declares Q4FY22 result:

  • Revenue growth led by better product mix & price realization
  • Gross Margins were marginally impacted by higher freight costs
  • Growth in EBITDA driven by higher revenues, effective cost management marginally setted off by higher freight cost
  • PBT grew due to better operating leverage. However, it was partly impacted by higher depreciation.
  • PAT grew by 32% to Rs. 177 crores

 

Result PDF

Trending News

Royal Enfield Slates ₹2,500 Cr Greenfield Unit in AP; CapEx to Boost Global Mid-Size Bike Growth

In a press release, Royal Enfield has announced plans for a major manufacturing expansion with the proposed acquisition of land in Tada, near Tirupati in Andhra Pradesh, for a new greenfield facility. 

Published on 19-May-2026 09:07

Happiest Minds: GenAI Entry Structurally Positive; Platform Shifts to Drive Sustained IT Growth

Happiest Minds Technologies stated that the recent entry of GenAI platform providers such as OpenAI (US$ 4 bn fund raise for The Deployment Company) and Anthropic ($1.5 billion joint venture) into enterprise services is structurally positive for IT services firms and will accelerate AI adoption rather than disrupt the sector. 

Published on 19-May-2026 09:06

Tata Consumer Q4: New-Age Channels Fuel 41% India Sales; Tata Sampann Hits ₹1,500 Cr

As per FY26 annual report, Tata Consumer Products (TCPL) highlighted a strong long-term growth outlook for India, supported by favourable demographics, rising disposable incomes and increasing health & wellness consumption trends. 

Published on 19-May-2026 09:05

Rishabh Instruments Q4 Net Profit Triples to ₹20 Cr; EBITDA Surges 106% on Turnaround

Rishabh Instruments reported a healthy operational performance in Q4FY26 with consolidated revenue growing 9.3% YoY to ₹205 crore, while EBITDA surged 106% YoY to ₹33.3 crore led by improved product mix, operating leverage and turnaround in the HPDC business. 

Published on 19-May-2026 09:04

Timken India Q4 Revenue Jumps 14.5% to ₹1,090 Cr; Net Profit Drops 16.8% On Higher Taxes

Timken India Limited reported Q4FY26 revenue growth of 14.5% YoY to ₹1,090 crore, driven by healthy demand across industrial and rail segments. 

Published on 19-May-2026 09:03

Astral Q4 profit jumps 19% to ₹213 Cr, revenue grows 24% to ₹2,089 Cr

Astral Limited reported strong Q4FY26 performance with consolidated revenue rising 24% YoY to ₹ 2,089 crore, driven by robust plumbing volume growth of 24% (84,041 MT). 

Published on 19-May-2026 09:02

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app